PRE-ORDER: ON SALE DATE: May 6, 2025 

A riveting look at the tremendous promise and inherent risks of the use of psychedelics in mental health treatment through the lens of a New York Times reporter whose journalistic exploration of this emerging field began with a personal crisis.

• NOW IN PAPERBACK WITH NEW ORIGINAL MATERIAL -- Since the initial publication, there will undoubtedly be further decriminalization and therapeutic uses for psychedelics for mental health. We will update book accordingly in new Readers Group Guide material.
• Born and raised in Bogotá, Colombia, Londoño ascended to the top echelons of American journalism at an early age. He covered the wars in Iraq and Afghanistan for the Washington Post and later joined the New York Times, where he served on the editorial board and as Brazil bureau chief. As a trilingual, bicultural narrator, Londoño writes poignantly about the role of psychedelics in healing his depression and changing his outlook on the intergenerational mental health battles within his own family.
• The therapeutic potential of psychedelics is widely regarded as a potential game changer in mental health treatment. The Food and Drug Administration is widely expected to approve the use of MDMA-assisted therapy in 2024. Two states (Colorado and Oregon) and several cities have recently decriminalized psychedelics as their recreational and therapeutic use grows.
• Takes readers behind the scenes of the first MDMA trial conducted at a Veterans Affairs hospital, which marked the first time the federal government administered psychedelics as an experimental medicine since the 1960s. It also sheds new light on the decades-long quest to use religious freedom laws to expand access to illegal drugs in spiritual settings. Trippy will be the most thorough examination to date of the emerging field of therapeutic psychedelics.
• The book was acquired with both the author and The New York Times, who will promote it heavily through advertising (on site and email newsletters) and earned media. The #1 NYT bestseller THE 1619 PROJECT by Nikole Hannah-Jones was a similar arrangement.

"New York Times correspondent Londoño debuts with an arresting survey of the “medicinal psychedelic field” and where it’s headed...a scrupulous study of a fascinating development in mental health care.”
—Publishers Weekly, starred review

“Blending solid research and personal experience, the author points to a new frontier for trauma treatment.”
—Kirkus

“An engaging memoir…Trippy is a fascinating account of the world of medicinal psychedelics.”
—LA Times

“A moving, tender and thoughtful exploration of a complicated subject. If you want to understand psychedelics better, this is a great place to start.”
—Johann Hari, New York Times bestselling author of Stolen Focus and Lost Connections

"A compulsively readable romp through a burgeoning scene that has immense potential for both harm and healing."
—Dan Harris, New York Times bestselling author of 10% Happier and host of the Ten Percent Happier podcast (1/7/2025)